CHD4 promotes acquired chemoresistance and tumor progression by activating the MEK/ERK axis
Open Access
- 26 December 2022
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 66, 100913
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- The major vault protein mediates resistance to epidermal growth factor receptor inhibition in human hepatoma cellsCancer Letters, 2012
- Molecular mechanisms of cisplatin resistanceOncogene, 2011
- Cancer biology and NuRD: a multifaceted chromatin remodelling complexNature Reviews Cancer, 2011
- A chromatin localization screen reveals poly (ADP ribose)-regulated recruitment of the repressive polycomb and NuRD complexes to sites of DNA damageProceedings of the National Academy of Sciences, 2010
- The chromatin-remodeling factor CHD4 coordinates signaling and repair after DNA damageJournal of Cell Biology, 2010
- The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasisCell Research, 2010
- Regulation of DNA‐damage responses and cell‐cycle progression by the chromatin remodelling factor CHD4The EMBO Journal, 2010
- On the role of major vault protein in the resistance of senescent human diploid fibroblasts to apoptosisCell Death & Differentiation, 2008
- Nuclear Localization of PTEN Is Regulated by Ca2+ through a Tyrosil Phosphorylation–Independent Conformational Modification in Major Vault ProteinCancer Research, 2006
- The Major Vault Protein Is a Novel Substrate for the Tyrosine Phosphatase SHP-2 and Scaffold Protein in Epidermal Growth Factor SignalingJournal of Biological Chemistry, 2004